Literature DB >> 31911778

Headache, Delirium or Encephalitis? A Case of Residual Mutism Secondary to Anti-NMDA Receptor Encephalitis.

Omar Jiménez-Zarazúa1,2, María Andrea Martínez-Rivera1,2, Pedro Luis González-Carrillo3, Lourdes N Vélez-Ramírez2,4, María Alcocer-León2,5, Sandra X L Tafoya-Rojas6, Angélica M Becerra-Baez2, Mariana A Bravo-Martínez7, Jaime D Mondragón8,9.   

Abstract

Encephalitis is a heterogeneous syndrome that is diagnosed through clinical assessment and the assistance of laboratory, neuroimaging and electroencephalographic workup. Over the past 10 years, autoimmune encephalitis has been more frequently recognized; however, most reports come from highly specialized hospital settings. Anti-N-methyl-D-aspartate receptor (NDMAR) encephalitis has been associated with paraneoplastic encephalitis syndromes and was first recognized in 2005. We present the case of a 34-year-old male patient who debuted clinically with a headache associated with neuropsychiatric symptoms (i.e., visual and auditory hallucinations, anxiety, aggressiveness) and memory deficits, progressing to autonomic dysfunction (i.e., tachycardia and hypertension), seizures, and stupor with catatonic features. Initially, infectious, metabolic, and toxicological etiologies were excluded; followed by the assessment of immunological and paraneoplastic etiologies, yielding positive IgG levels for anti-NMDAR antibodies. The patient was treated successfully with systemic steroid therapy and therapeutic plasmapheresis, while mutism was the only sequela. Although large case series reporting on paraneoplastic and autoimmune anti-NMDAR encephalitis have been reported in the literature in recent years, this case is of particular importance due to the stepwise differential diagnosis and treatment management procedure that was used in a regional but not highly specialized hospital setting.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Anti-N-methyl-D-aspartate receptor encephalitis; Delirium; Headache disorders; Mutism

Year:  2019        PMID: 31911778      PMCID: PMC6940434          DOI: 10.1159/000504016

Source DB:  PubMed          Journal:  Case Rep Neurol        ISSN: 1662-680X


  24 in total

Review 1.  An evolving redefinition of autoimmune encephalitis.

Authors:  Susanna Esposito; Nicola Principi; Paolo Calabresi; Donato Rigante
Journal:  Autoimmun Rev       Date:  2018-12-18       Impact factor: 9.754

2.  Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma.

Authors:  M S Zandi; S R Irani; G Follows; A M Moody; P Molyneux; A Vincent
Journal:  Neurology       Date:  2009-12-08       Impact factor: 9.910

3.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

Review 4.  Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.

Authors:  Joseph Schwartz; Anand Padmanabhan; Nicole Aqui; Rasheed A Balogun; Laura Connelly-Smith; Meghan Delaney; Nancy M Dunbar; Volker Witt; Yanyun Wu; Beth H Shaz
Journal:  J Clin Apher       Date:  2016-06       Impact factor: 2.821

Review 5.  Antibody-Mediated Encephalitis.

Authors:  Josep Dalmau; Francesc Graus
Journal:  N Engl J Med       Date:  2018-03-01       Impact factor: 91.245

6.  Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin.

Authors:  H Prüss; J Dalmau; L Harms; M Höltje; G Ahnert-Hilger; K Borowski; W Stoecker; K P Wandinger
Journal:  Neurology       Date:  2010-11-09       Impact factor: 9.910

7.  Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium.

Authors:  A Venkatesan; A R Tunkel; K C Bloch; A S Lauring; J Sejvar; A Bitnun; J-P Stahl; A Mailles; M Drebot; C E Rupprecht; J Yoder; J R Cope; M R Wilson; R J Whitley; J Sullivan; J Granerod; C Jones; K Eastwood; K N Ward; D N Durrheim; M V Solbrig; L Guo-Dong; C A Glaser
Journal:  Clin Infect Dis       Date:  2013-07-15       Impact factor: 9.079

8.  Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis.

Authors:  Matthew S Kayser; Maarten J Titulaer; Núria Gresa-Arribas; Josep Dalmau
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302

Review 9.  Diagnostic Testing of Neurologic Infections.

Authors:  Prashanth S Ramachandran; Michael R Wilson
Journal:  Neurol Clin       Date:  2018-11       Impact factor: 3.806

10.  Prodromal headache in anti-NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity.

Authors:  Naomi Tominaga; Naomi Kanazawa; Atsushi Kaneko; Juntaro Kaneko; Eiji Kitamura; Hiroto Nakagawa; Kazutoshi Nishiyama; Takahiro Iizuka
Journal:  Brain Behav       Date:  2018-06-01       Impact factor: 2.708

View more
  1 in total

Review 1.  Autoimmune Encephalitis in Latin America: A Critical Review.

Authors:  Gabriel de Albuquerque Vasconcelos; Rodrigo Montenegro Barreira; Karmelita Emanuelle Nogueira Torres Antoniollo; Alina Maria Nuñez Pinheiro; Cíntia Fernandes Rodrigues Maia; Danyela Martins Bezerra Soares Alves; Paulo Ribeiro Nóbrega; Pedro Braga-Neto
Journal:  Front Neurol       Date:  2021-01-21       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.